Redmile Group, LLC - Director, 10%+ Owner at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type: Company
Role: Director, 10%+ Owner
Stock Symbol: FATE on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Redmile Group, LLC - trading volume in the past year for Fate Therapeutics Inc

	Shares	%	Avg Price	Total $
Buys	+44.6K	100%	$3.72	+$166K
Sells
Net	+44.6K	100%		+$166K

Holdings reported by Redmile Group, LLC for Fate Therapeutics Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	12.8M	$54.3M	$4.23	Dec 12, 2024	Indirect
Pre-Funded Warrants to Purchase Common Stock	3.89M	$21.4M	$5.50	Mar 21, 2024	Indirect	Common Stock
Stock Option (Right to Buy)	40K	$109K	$2.73	Jun 7, 2024	Indirect	Common Stock
Class A Convertible Preferred Stock	2.76M			Dec 12, 2024	Indirect	Common Stock

Transactions reported by Redmile Group, LLC for Fate Therapeutics Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.